Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
FDA Advisory Committee Recommends Approval of New Alzheimer’s Drug
Wegovy and Ozempic Cost So Much, U.S. Lawmakers Are Intervening
How to Read News Articles About Dementia — And Spot Hype and Exaggeration
A Roadmap for Couples Facing a Dementia Diagnosis In NYC
Aging Means More Vulnerability to Financial Scams—How to Spot Them
APOE4 Jacks Alzheimer’s Risk. This Gene Could Be an Antidote
Annovis Bio’s Experimental Alzheimer’s Capsule Falls Short in Latest Trial
Cleaner Air Could Spare 188,000 Americans From Dementia Each Year
‘I Discovered I Had Obstructive Sleep Apnea—Here’s How It Affected My Brain’
Tau Protein: Coming to New Alzheimer’s Diagnostics and Treatments Near You
Exploring Flashing Lights and Sounds to Slow Alzheimer’s Brain Shrinkage
Alzheimer’s Rates Are Highest In These Counties—But No Leqembi Access
Alzheimer’s Drug Types 101: What Are Biologics?
Alzheimer’s Drug Types 101: What Are Small Molecule Drugs?
How Policymakers Around the World Are Planning for a Dementia Surge
Previous
13
14
15
Next
Page load link
Go to Top